Nanoplastics increase in vitro oestrogenic activity of neurotherapeutic drugs

1. EUR-Lex. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions - Towards a comprehensive European international investment policy /* COM/2010/0343 final */[displayed 5 March 2024]. Available at https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A52010DC0343 EUR-Lex Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions - Towards a comprehensive European international investment policy /* COM/2010/0343 final */[displayed 5 March 2024] Available at https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A52010DC0343 Search in Google Scholar

2. Cho YJ, Yun JH, Kim SJ, Kwon HY. Nonpersistent endocrine disrupting chemicals and reproductive health of women. Obstet Gynecol Sci 2020;63:1–12. doi: 10.5468/ogs.2020.63.1.1 ChoYJ YunJH KimSJ KwonHY Nonpersistent endocrine disrupting chemicals and reproductive health of women Obstet Gynecol Sci 2020 63 1 12 10.5468/ogs.2020.63.1.1 Open DOISearch in Google Scholar

3. United Nations Environment Programme (UNEP), World Health Organization (WHO). State of the science of endocrine disrupting chemicals – 2012. Geneva: UNEP/WHO, 2012 [displayed 6 March 2024]. Available at: https://iris.who.int/bitstream/handle/10665/78101/9789241505031_eng.pdf?sequence=1 United Nations Environment Programme (UNEP), World Health Organization (WHO) State of the science of endocrine disrupting chemicals – 2012 Geneva UNEP/WHO 2012 [displayed 6 March 2024]. Available at: https://iris.who.int/bitstream/handle/10665/78101/9789241505031_eng.pdf?sequence=1 Search in Google Scholar

4. Rutkowska AZ, Diamanti-Kandarakis E. Polycystic ovary syndrome and environmental toxins. Fertil Steril 2016;106:948–58. doi: 10.1016/j.fertnstert.2016.08.031 RutkowskaAZ Diamanti-KandarakisE Polycystic ovary syndrome and environmental toxins Fertil Steril 2016 106 948 58 10.1016/j.fertnstert.2016.08.031 Open DOISearch in Google Scholar

5. OECD Guidelines for the Testing of Chemicals, Section 4. Test No. 455: Performance-Based Test Guideline for Stably Transfected Transactivation In Vitro Assays to Detect Estrogen Receptor Agonists and Antagonists, 2021 [displayed 5 March 2024]. Available at https://doi.org/10.1787/9789264265295-en OECD Guidelines for the Testing of Chemicals, Section 4 Test No. 455: Performance-Based Test Guideline for Stably Transfected Transactivation In Vitro Assays to Detect Estrogen Receptor Agonists and Antagonists 2021 [displayed 5 March 2024]. Available at https://doi.org/10.1787/9789264265295-en Search in Google Scholar

6. Sabir S, Akhtar MF, Saleem A. Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals. Environ Sci Pollut Res Int 2019;26:1277–86. doi: 10.1007/s11356-018-3774-4 SabirS AkhtarMF SaleemA Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals Environ Sci Pollut Res Int 2019 26 1277 86 10.1007/s11356-018-3774-4 Open DOISearch in Google Scholar

7. Batucan NSP, Tremblay LA, Northcott GL, Matthaei CD. Medicating the environment? A critical review on the risks of carbamazepine, diclofenac and ibuprofen to aquatic organisms. Environ Adv 2022;7:100164–78. doi: 10.1016/j.envadv.2021.100164 BatucanNSP TremblayLA NorthcottGL MatthaeiCD Medicating the environment? A critical review on the risks of carbamazepine, diclofenac and ibuprofen to aquatic organisms Environ Adv 2022 7 100164 78 10.1016/j.envadv.2021.100164 Open DOISearch in Google Scholar

8. Küster A, Adler N. Pharmaceuticals in the environment: scientific evidence of risks and its regulation. Philos Trans R Soc Lond B Bio Sci 2014;369(1656):20130587–95. doi: 10.1098/rstb.2013.0587 KüsterA AdlerN Pharmaceuticals in the environment: scientific evidence of risks and its regulation Philos Trans R Soc Lond B Bio Sci 2014 369 1656 20130587 95 10.1098/rstb.2013.0587 Open DOISearch in Google Scholar

9. Batke M, Damm G, Foth H, Freyberger A, Gebel T, Gundert-Remy U, Hengstler J, Mangerich A, Partosch F, Röhl C, Schupp T, Wollin KM. The EU chemicals strategy for sustainability: critical reflections on proposed regulatory changes for endocrine disruptors and mixture toxicity. Arch Toxicol 2022;96:1133–5. doi: 10.1007/s00204-022-03227-z BatkeM DammG FothH FreybergerA GebelT Gundert-RemyU HengstlerJ MangerichA PartoschF RöhlC SchuppT WollinKM The EU chemicals strategy for sustainability: critical reflections on proposed regulatory changes for endocrine disruptors and mixture toxicity Arch Toxicol 2022 96 1133 5 10.1007/s00204-022-03227-z Open DOISearch in Google Scholar

10. McEntaggart K, Chirico S, Etienne J, Rigoni M, Papoutsis S, Leather J. EFSA EU Insights Chemical mixtures awareness, understanding and risk perceptions. EFSA Support Publ 2019;EN-1602. doi: 10.2903/sp.efsa.2019.EN-1602 McEntaggartK ChiricoS EtienneJ RigoniM PapoutsisS LeatherJ EFSA EU Insights Chemical mixtures awareness, understanding and risk perceptions EFSA Support Publ 2019 EN-1602 10.2903/sp.efsa.2019.EN-1602 Open DOISearch in Google Scholar

11. OECD. Considerations for Assessment of Risk from the Combined Exposure to Multiple Chemicals. Series on Testing and Assessment No. 296, 2018 [displayed 5 March 2024]. Availble at chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.oecd.org/chemicalsafety/risk-assessment/considerations-for-assessing-the-risks-of-combined-exposure-to-multiple-chemicals.pdf OECD Considerations for Assessment of Risk from the Combined Exposure to Multiple Chemicals. Series on Testing and Assessment No. 296 2018 [displayed 5 March 2024]. Availble at chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.oecd.org/chemicalsafety/risk-assessment/considerations-for-assessing-the-risks-of-combined-exposure-to-multiple-chemicals.pdf Search in Google Scholar

12. Sharma S, Chatterjee S. Microplastic pollution, a threat to marine ecosystem and human health: a short review. Environ Sci Pollut Res Int 2017;24:21530–47. doi: 10.1007/s11356-017-9910-8 SharmaS ChatterjeeS Microplastic pollution, a threat to marine ecosystem and human health: a short review Environ Sci Pollut Res Int 2017 24 21530 47 10.1007/s11356-017-9910-8 Open DOISearch in Google Scholar

13. Lehner R, Weder C, Petri-Fink A, Rothen-Rutishauser B. Emergence of nanoplastic in the environment and possible impact on human health. Environ Sci Technol 2019;53:1748–65. doi: 10.1021/acs.est.8b05512 LehnerR WederC Petri-FinkA Rothen-RutishauserB Emergence of nanoplastic in the environment and possible impact on human health Environ Sci Technol 2019 53 1748 65 10.1021/acs.est.8b05512 Open DOISearch in Google Scholar

14. Katsumiti A, Losada-Carrillo MP, Barros M, Cajaraville MP. Polystyrene nanoplastics and microplastics can act as Trojan horse carriers of benzo(a)pyrene to mussel hemocytes in vitro. Sci Rep 2021;11(1):22396. doi: 10.1038/s41598-021-01938-4 KatsumitiA Losada-CarrilloMP BarrosM CajaravilleMP Polystyrene nanoplastics and microplastics can act as Trojan horse carriers of benzo(a)pyrene to mussel hemocytes in vitro Sci Rep 2021 11 1 22396 10.1038/s41598-021-01938-4 Open DOISearch in Google Scholar

15. Mezzelani M, Peruzza L, D’Errico G, Milan M, Gorbi S, Regoli F. Mixtures of environmental pharmaceuticals in marine organisms: Mechanistic evidence of carbamazepine and valsartan effects on Mytilus galloprovincialis. Sci Total Environ 2023;860:160465. doi: 10.1016/j.scitotenv.2022.160465 MezzelaniM PeruzzaL D’ErricoG MilanM GorbiS RegoliF Mixtures of environmental pharmaceuticals in marine organisms: Mechanistic evidence of carbamazepine and valsartan effects on Mytilus galloprovincialis Sci Total Environ 2023 860 160465 10.1016/j.scitotenv.2022.160465 Open DOISearch in Google Scholar

16. Batucan NSP, Tremblay LA, Northcott GL, Matthaei CD. Medicating the environment? A critical review on the risks of carbamazepine, diclofenac and ibuprofen to aquatic organisms. Environ Adv 2022;7:100164. doi: 10.1016/j.envadv.2021.100164 BatucanNSP TremblayLA NorthcottGL MatthaeiCD Medicating the environment? A critical review on the risks of carbamazepine, diclofenac and ibuprofen to aquatic organisms Environ Adv 2022 7 100164 10.1016/j.envadv.2021.100164 Open DOISearch in Google Scholar

17. Ács A, Liang X, Bock I, Griffitts J, Ivánovics B, Vásárhelyi E, Ferincz Á, Pirger Z, Urbányi B, Csenki Z. Chronic effects of carbamazepine, progesterone and their mixtures at environmentally relevant concentrations on biochemical markers of zebrafish (Danio rerio). Antioxidants 2022;11(9):1776. doi: 10.3390/antiox11091776 ÁcsA LiangX BockI GriffittsJ IvánovicsB VásárhelyiE FerinczÁ PirgerZ UrbányiB CsenkiZ Chronic effects of carbamazepine, progesterone and their mixtures at environmentally relevant concentrations on biochemical markers of zebrafish (Danio rerio) Antioxidants 2022 11 9 1776 10.3390/antiox11091776 Open DOISearch in Google Scholar

18. Almeida Â, Soares AMVM, Esteves VI, Freitas R. Occurrence of the antiepileptic carbamazepine in water and bivalves from marine environments: A review. Environ Toxicol Pharmacol 2021;86:103661. doi: 10.1016/j.etap.2021.103661 Almeida SoaresAMVM EstevesVI FreitasR Occurrence of the antiepileptic carbamazepine in water and bivalves from marine environments: A review Environ Toxicol Pharmacol 2021 86 103661 10.1016/j.etap.2021.103661 Open DOISearch in Google Scholar

19. Mezzelani M, Nardi A, Bernardini I, Milan M, Peruzza L, d’Errico G, Fattorini D, Gorbi S, Patarnello T, Regoli F. Environmental pharmaceuticals and climate change: The case study of carbamazepine in M. galloprovincialis under ocean acidification scenario. Environ Int 2021;146:106269. doi: 10.1016/j.envint.2020.106269 MezzelaniM NardiA BernardiniI MilanM PeruzzaL d’ErricoG FattoriniD GorbiS PatarnelloT RegoliF Environmental pharmaceuticals and climate change: The case study of carbamazepine in M. galloprovincialis under ocean acidification scenario Environ Int 2021 146 106269 10.1016/j.envint.2020.106269 Open DOISearch in Google Scholar

20. Correia D, Domingues I, Faria M, Oliveira M. Effects of fluoxetine on fish: What do we know and where should we focus our efforts in the future? Sci Total Environ 2023;857:159486. doi: 10.1016/j.scitotenv.2022.159486 CorreiaD DominguesI FariaM OliveiraM Effects of fluoxetine on fish: What do we know and where should we focus our efforts in the future? Sci Total Environ 2023 857 159486 10.1016/j.scitotenv.2022.159486 Open DOISearch in Google Scholar

21. Nentwig G. Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine. Arch Environ Contam Toxicol 2007;52:163–70. doi: 10.1007/s00244-005-7190-7 NentwigG Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine Arch Environ Contam Toxicol 2007 52 163 70 10.1007/s00244-005-7190-7 Open DOISearch in Google Scholar

22. Oakes KD, Coors A, Escher BI, Fenner K, Garric J, Gust M, Knacker T, Küster A, Kussatz C, Metcalfe CD, Monteiro S, Moon TW, Mennigen JA, Parrott J, Péry AR, Ramil M, Roennefahrt I, Tarazona JV, Sánchez-Argüello P, Ternes TA, Trudeau VL, Boucard T, Van Der Kraak GJ, Servos MR. Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework. Integr Environ Assess Manag 2010;6(Suppl):524–39. doi: 10.1002/ieam.77 OakesKD CoorsA EscherBI FennerK GarricJ GustM KnackerT KüsterA KussatzC MetcalfeCD MonteiroS MoonTW MennigenJA ParrottJ PéryAR RamilM RoennefahrtI TarazonaJV Sánchez-ArgüelloP TernesTA TrudeauVL BoucardT Van Der KraakGJ ServosMR Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework Integr Environ Assess Manag 2010 6 Suppl 524 39 10.1002/ieam.77 Open DOISearch in Google Scholar

23. Yamindago A, Lee N, Lee N, Jo Y, Woo S, Yum S. Fluoxetine in the environment may interfere with the neurotransmission or endocrine systems of aquatic animals. Ecotoxicol Environ Saf 2021;227:112931. doi: 10.1016/j.ecoenv.2021.112931 YamindagoA LeeN LeeN JoY WooS YumS Fluoxetine in the environment may interfere with the neurotransmission or endocrine systems of aquatic animals Ecotoxicol Environ Saf 2021 227 112931 10.1016/j.ecoenv.2021.112931 Open DOISearch in Google Scholar

24. Correia D, Bellot M, Prats E, Gómez-Canela C, Moro H, Raldúa D, Domingues I, Oliveira M, Faria M. Impact of environmentally relevant concentrations of fluoxetine on zebrafish larvae: from gene to behavior. Chemosphere 2023;345:140468. doi: 10.1016/j.chemosphere.2023.140468 CorreiaD BellotM PratsE Gómez-CanelaC MoroH RaldúaD DominguesI OliveiraM FariaM Impact of environmentally relevant concentrations of fluoxetine on zebrafish larvae: from gene to behavior Chemosphere 2023 345 140468 10.1016/j.chemosphere.2023.140468 Open DOISearch in Google Scholar

25. Lupu D, Sjödin MOD, Varshney M, Lindberg J, Loghin F, Rüegg J. Fluoxetine modulates sex steroid levels in vitro. Clujul Med 2017;90:420–4. doi: 10.15386/cjmed-868 LupuD SjödinMOD VarshneyM LindbergJ LoghinF RüeggJ Fluoxetine modulates sex steroid levels in vitro Clujul Med 2017 90 420 4 10.15386/cjmed-868 Open DOISearch in Google Scholar

26. Jacobsen NW, Hansen CH, Nellemann C, Styrishave B, Halling-Sørensen B. Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay. Toxicol in Vitro 2015;29:1729–35. doi: 10.1016/j.tiv.2015.07.005 JacobsenNW HansenCH NellemannC StyrishaveB Halling-SørensenB Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay Toxicol in Vitro 2015 29 1729 35 10.1016/j.tiv.2015.07.005 Open DOISearch in Google Scholar

27. Pop A, Lupu DI, Cherfan J, Kiss B, Loghin F. Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors. Clujul Med 2015;88:381–5. doi: 10.15386/cjmed-474 PopA LupuDI CherfanJ KissB LoghinF Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors Clujul Med 2015 88 381 5 10.15386/cjmed-474 Open DOISearch in Google Scholar

28. Müller JC, Imazaki PH, Boareto AC, Lourenço EL, Golin M, Vechi MF, Lombardi NF, Minatovicz BC, Scippo ML, Martino-Andrade AJ, Dalsenter PR. In vivo and in vitro estrogenic activity of the antidepressant fluoxetine. Reprod Toxicol 2012;34:80–5. doi: 10.1016/j.reprotox.2012.04.001 MüllerJC ImazakiPH BoaretoAC LourençoEL GolinM VechiMF LombardiNF MinatoviczBC ScippoML Martino-AndradeAJ DalsenterPR In vivo and in vitro estrogenic activity of the antidepressant fluoxetine Reprod Toxicol 2012 34 80 5 10.1016/j.reprotox.2012.04.001 Open DOISearch in Google Scholar

29. USEPA. Endocrine Disruptor Screening Program Test Guidelines - OPPTS 890.1300: Estrogen Receptor Transcriptional Activation (Human Cell Line (HeLa-9903)) [EPA 740-C-09-006] [displayed 5 March 2024]. Available at https://www.regulations.gov/document/EPA-HQ-OPPT-2009-0576-0006 USEPA Endocrine Disruptor Screening Program Test Guidelines - OPPTS 890.1300: Estrogen Receptor Transcriptional Activation (Human Cell Line (HeLa-9903)) [EPA 740-C-09-006] [displayed 5 March 2024]. Available at https://www.regulations.gov/document/EPA-HQ-OPPT-2009-0576-0006 Search in Google Scholar

30. Wilson VS, Bobseine K, Gray LE Jr. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Toxicol Sci 2004;81:69–77. doi: 10.1093/toxsci/kfh180 WilsonVS BobseineK GrayLEJr Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists Toxicol Sci 2004 81 69 77 10.1093/toxsci/kfh180 Open DOISearch in Google Scholar

31. Shen M, Zhang Y, Zhu Y, Song B, Zeng G, Hu D, Wen X, Ren X. Recent advances in toxicological research of nanoplastics in the environment: A review. Environ Pollut 2019;252:511–21. doi: 10.1016/j.envpol.2019.05.102 ShenM ZhangY ZhuY SongB ZengG HuD WenX RenX Recent advances in toxicological research of nanoplastics in the environment: A review Environ Pollut 2019 252 511 21 10.1016/j.envpol.2019.05.102 Open DOISearch in Google Scholar

32. Ali I, Cheng Q, Ding T, Yiguang Q, Yuechao Z, Sun H, Peng C, Naz I, Li J, Liu J. Micro- and nanoplastics in the environment: Occurrence, detection, characterization and toxicity – A critical review. J Clean Prod 2021;313:127863. doi: 10.1016/j.jclepro.2021.127863 AliI ChengQ DingT YiguangQ YuechaoZ SunH PengC NazI LiJ LiuJ Micro- and nanoplastics in the environment: Occurrence, detection, characterization and toxicity – A critical review J Clean Prod 2021 313 127863 10.1016/j.jclepro.2021.127863 Open DOISearch in Google Scholar

33. Xu JL, Lin X, Wang JJ, Gowen AA. A review of potential human health impacts of micro- and nanoplastics exposure. Sci Total Environ 2022;851:158111. doi: 10.1016/j.scitotenv.2022.158111 XuJL LinX WangJJ GowenAA A review of potential human health impacts of micro- and nanoplastics exposure Sci Total Environ 2022 851 158111 10.1016/j.scitotenv.2022.158111 Open DOISearch in Google Scholar

34. Malich G, Markovic B, Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 1997;124(3):179–92. doi: 10.1016/S0300-483X(97)00151-0 MalichG MarkovicB WinderC The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines Toxicology 1997 124 3 179 92 10.1016/S0300-483X(97)00151-0 Open DOISearch in Google Scholar

35. Sakuratani Y, Horie M, Leinala E. Integrated approaches to testing and assessment: OECD activities on the development and use of adverse outcome pathways and case studies. Basic Clin Pharmacol Toxicol 2018;123(Suppl 5):20–8. doi: 10.1111/bcpt.12955 SakurataniY HorieM LeinalaE Integrated approaches to testing and assessment: OECD activities on the development and use of adverse outcome pathways and case studies Basic Clin Pharmacol Toxicol 2018 123 Suppl 5 20 8 10.1111/bcpt.12955 Open DOISearch in Google Scholar

36. Delrue N, Sachana M, Sakuratani Y, Gourmelon A, Leinala E, Diderich R. The adverse outcome pathway concept: A basis for developing regulatory decision-making dools. Altern Lab Anim 2016;44:417–29. doi: 10.1177/026119291604400504 DelrueN SachanaM SakurataniY GourmelonA LeinalaE DiderichR The adverse outcome pathway concept: A basis for developing regulatory decision-making dools Altern Lab Anim 2016 44 417 29 10.1177/026119291604400504 Open DOISearch in Google Scholar

37. Vinken M. The adverse outcome pathway concept: A pragmatic tool in toxicology. Toxicology 2013;312:158–65. doi: 10.1016/j.tox.2013.08.011 VinkenM The adverse outcome pathway concept: A pragmatic tool in toxicology Toxicology 2013 312 158 65 10.1016/j.tox.2013.08.011 Open DOISearch in Google Scholar